| Date Filed | Type | Description |
| 08/14/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Immix Biopharma, Inc.|
Txns:
| Granted 20,000 options
@ $1.86, valued at
$37.2k
|
|
| 08/03/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.2834, valued at
$12.8k
|
|
| 05/10/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 9,500 options to buy
@ $0.2985, valued at
$2.8k
|
|
| 01/10/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 10,600 options to buy
@ $23.23, valued at
$246.2k
Granted 3,900 restricted stock units
@ $0 |
|
| 12/19/2022 |
4
| Marquet Magda (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Bought 2,222 shares
@ $18, valued at
$40k
|
|
| 07/18/2022 |
4
| Marquet Magda (Director) has filed a Form 4 on Immix Biopharma, Inc.|
Txns:
| Granted 16,000 options
@ $2.64, valued at
$42.2k
|
|
| 06/27/2022 |
4
| Marquet Magda (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $16.02, valued at
$240.3k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Marquet Magda (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 9,200 options to buy
@ $30.44, valued at
$280k
|
|
| 12/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/08/2021 |
3
| Marquet Magda (Director) has filed a Form 3 on Transcode Therapeutics, Inc. |
| 06/22/2021 |
4
| Marquet Magda (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $35.09, valued at
$526.4k
|
|
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Marquet Magda (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 11,000 options to buy
@ $26.11, valued at
$287.2k
Granted 784 options to buy
@ $26.11, valued at
$20.5k
|
|
| 01/19/2021 |
3
| Marquet Magda (Director) has filed a Form 3 on ANAPTYSBIO, INC |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2020 |
4
| Marquet Magda (Director) has filed a Form 4 on Pfenex Inc.|
Txns:
| Granted 18,000 options to buy
@ $6.43, valued at
$115.7k
|
|
| 10/29/2019 |
4
| Marquet Magda (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $10.23, valued at
$153.5k
|
|
| 09/17/2019 |
4
| Marquet Magda (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Bought 2,300 shares
@ $10.58, valued at
$24.3k
|
|
| 03/04/2019 |
4
| Marquet Magda (Director) has filed a Form 4 on Pfenex Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.49, valued at
$112.3k
|
|
| 03/04/2019 |
3
| Marquet Magda (Director) has filed a Form 3 on Pfenex Inc. |
| 01/02/2019 |
3
| Marquet Magda (Director) has filed a Form 3 on Arcturus Therapeutics Ltd. |